Board of Pharmacy Delays Requirement That Sole Proprietors Obtain Terminal Distributor’s License In Order to Compound Or Possess Compounded Drugs
by: Eric J. Plinke, Daniel S. Zinsmaster, Sarah C. Persinger, PharmD, RPh of Dinsmore & Shohl LLP  -  Insight
Saturday, June 18, 2016

The Ohio State Board of Pharmacy (Board) has extended the deadline for sole proprietors to obtain a Terminal Distributor of Dangerous Drugs (TDDD) license to September 1, 2016. We previously alerted you that as of May 1, 2016, the Board requires any prescriber who will possess, have custody or control of, or distribute dangerous drugs that are compounded or used for the purpose of compounding to be licensed as a TDDD.

After receiving feedback from impacted prescribers, the Board granted the extension to all prescribers who are performing drug compounding or ordering compounded drugs to their offices from the requirement to obtain a TDDD license. The Board will reconsider the scope of its new compounding rules and will provide further guidance following its July 2016 meeting.

It is important to note that this extension does not impact the implementation and enforcement of OAC 4729-16-11, which regulates prescriber compounding of hazardous drugs.

 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins